<DOC>
	<DOC>NCT00352768</DOC>
	<brief_summary>This study is to verify the efficacy of fluvoxamine maleate given for 10 weeks in treatment of children and adolescents with obsessive-compulsive disorder</brief_summary>
	<brief_title>Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Fluvoxamine</mesh_term>
	<criteria>Inclusion Criteria Have a minimum total score of 16 on the JCYBOCS, Weight is within the standard weight Â± 2S.D. based on the standard weight for each age in the School Health Statistical Survey Exclusion Criteria Have the following predominant psychiatric diagnosis Schizophrenia Have previously been treated with fluvoxamine maleate</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Fluvoxamine Maleate</keyword>
	<keyword>OCD</keyword>
	<keyword>Children and Adolescents</keyword>
</DOC>